Outlook Therapeutics (OTLK) Net Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) Net Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Outlook Therapeutics | 89.70 Mn | 78.46 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2019 | 61,246.00 |
| Jun 30, 2019 | 97,321.00 |
| Mar 31, 2019 | -83,432.00 |
| Dec 31, 2018 | 71,220.00 |
| Sep 30, 2018 | -46,188.00 |
| Jun 30, 2018 | -6,818.00 |
| Mar 31, 2018 | 118,774.00 |
| Dec 31, 2017 | -203,632.00 |
| Sep 30, 2017 | 149,856.00 |
| Jun 30, 2017 | 89,550.00 |
| Mar 31, 2017 | 364,600.00 |
| Dec 31, 2016 | -416,481.00 |
| Sep 30, 2016 | 396,580.00 |
| Jun 30, 2016 | -564,157.00 |
| Mar 31, 2016 | 132,989.00 |
| Dec 31, 2015 | 190,294.00 |
| Sep 30, 2015 | -273,239.00 |
| Jun 30, 2015 | 208,777.00 |